Compare Moderna, Inc. (MRNA) vs SMX Security Matters plc (SMX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Moderna, Inc. vs SMX Security Matters plc — how do they compare? Moderna, Inc. trades at $59.78 (market cap $23.60B), while SMX Security Matters plc trades at $20.17 (market cap $16.38M). The key difference: Moderna, Inc. is far larger — about 1440.8× SMX Security Matters plc's market cap, and Moderna, Inc. is trading nearer its 52-week high, SMX Security Matters plc nearer its low. Which is the better fit depends on your goals.
| MRNA | SMX | |
|---|---|---|
Market Cap | $23.60B | $16.38M |
Sector | Health | Technology |
52-Week High | $81.80 | $295.56K |
52-Week Low | $22.36 | $12.87 |
Enterprise Value | $19.70B | $13.35M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Moderna (MRNA) trades at $59.66, down 3.49% in the last session amid broader biotech volatility. The stock shows a mixed technical picture with bullish overall signals but bearish moving averages. Fundamentally, revenue has declined from pandemic peaks to $1.92B in 2025, with net losses widening to -$2.82B. Recent positive developments include an EU RSV vaccine contract and progress in cancer immunotherapy trials, with Q2 2026 earnings due July 31.
Outlook remains speculative as Moderna transitions beyond COVID-19 vaccines. Opportunities lie in its expanding pipeline in oncology and flu vaccines, but risks include sustained losses, competitive pressure, and execution hurdles. Analyst consensus is cautious with a $49 price target below current levels, reflecting uncertainty over profitability timeline.
SMX trades at $17.66, up 6.9% today, with a bullish technical signal supported by strong ADX readings. The stock shows negative profitability metrics, including a -2,216.26% ROE, but recent news highlights balance sheet strengthening and commercialization progress in recycled plastics traceability.
The outlook hinges on execution of its circular economy platform amid regulatory tailwinds, but high financial losses and recent reverse stock splits signal substantial risk. Investor sentiment is cautiously optimistic due to policy-driven demand growth.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Moderna, Inc.
Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Read more on MRNA →About SMX Security Matters plc
SMX Security Matters plc is a digital authentication and tracking technology company that uses a chemical-based, invisible marker system to trace and verify products across global supply chains. Their technology creates a 'digital twin' of physical products, used for quality control, counterfeiting prevention, and ensuring sustainability compliance from raw materials to final sale. The company's solutions are applied across various industries, including precious materials, luxury goods, and fast-moving consumer goods.
Read more on SMX →
